This webinar will focus on how ImmunoScape used high-dimensional, mass cytometry-based immunophenotyping of circulating lymphocytes to compare phenotypic expression across patients and timepoints, and correlate these with post-RT tumor responses. An expansion in activated Ki-67+ CD8+ T cells was observed as a possible outcome of this synergy, thereby providing new insights which may support the development of optimal sequencing strategies.